Table 5.
Association between patients’ characteristics and visual acuity at the final follow-up using submacular hemorrhage as a factor (n = 46).
| Morphologic features | P-value* | β | 95% confidence interval |
|---|---|---|---|
| Age | 0.044 | 1.159 | 1.004–1.339 |
| Sex | 0.260 | ||
| Diabetes mellitus | 0.199 | ||
| Hypertension | 0.155 | ||
| Use of anticoagulants | 0.423 | ||
| Systolic blood pressure | 0.483 | ||
| Diastolic blood pressure | 0.865 | ||
| Extent of hemorrhage | 0.552 | ||
| Submacular hemorrhage | 0.041 | 9.671 | 1.041–89.822 |
| Foveal involvement (hemorrhage vs. exudation) | 0.841 | ||
| Treatment (intravitreal bevacizumab vs. observation) | 0.788 |
*Statistical analysis was performed using binary logistic regression.